Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Ahsas Goyal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease is among the most common forms of neurodegenerative illness, with present treatment being primarily symptomatic and frequently coming with substantial adverse effects. Neuronal degeneration may arise due to a variety of pathological events, like inflammatory responses, neurotransmitter dysregulation, oxidative damage, mitochondrial malfunction, apoptosis, and genetic factors. The health issue and financial burden brought on by Parkinson's disease can worsen as the population ages. In the search for new and secure therapeutic agents for Parkinson's disease, several natural compounds have been shown to exert considerable neuroprotective benefits. Crocin, a naturally occurring carotenoid molecule, was found to have neuroprotective potential in the therapy of this disorder. Taking into account, the outcomes of various studies and the restorative actions of crocin, the present study emphasized the protective ability of crocin in this disease. Given the strong evidence supporting the neuroprotective ability of crocin, it is inferred that crocin inhibits inflammatory, apoptotic, and antioxidant processes through multiple mechanisms. Therefore, this compound is considered a safe and effective therapeutic choice for neurodegenerative illnesses like Parkinson's disease. However, more research on its efficacy as a treatment of Parkinson's disease is needed, specifically examining its mechanisms and the results obtained in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
- School of Health Sciences and Technology, University of Petroleum and Energy Studies, Bidohli, Uttarakhand, India.
ORCID-Profile: Ahsas Goyal, Aanchal Verma, Anant Agrawal, Nandini Dubey, Abhay Kumar, Tapan Behl
Zitieren
APA
Goyal, A., Verma, A., Agrawal, A., Dubey, N., Kumar, A., & Behl, T. (2023). Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14210
Vancouver
Goyal A, Verma A, Agrawal A, Dubey N, Kumar A, Behl T. Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14210
BibTeX
@article{Goyal2023,
author = {Goyal, Ahsas and Verma, Aanchal and Agrawal, Anant and Dubey, Nandini and Kumar, Abhay and Behl, Tapan},
title = {Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14210}
}
EUVIMED